Navigation Links
Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
Date:8/1/2013

are excluded. We believe such exclusion facilitates an understanding of the effects of the debt service obligations on the Company's liquidity and comparisons to peer group companies, and is reflective of how Auxilium management internally manages the business.(7)

The effects of non-cash tax benefit related to the acquisition of Actient is excluded because of its non-recurring nature. We believe such exclusion facilitates investors ability to more accurately compare our operating results to those of our peer companies. AUXILIUM PHARMACEUTICALS, INC.Table 2- Reconciliation of GAAP to Non-GAAP Net Income (Loss)(In millions, except per share amounts)(Unaudited)6 Months Ended June 30, 20136 Months Ended June 30, 2012GAAPAdjustmentsNon-GAAPGAAPAdjustmentsNon-GAAPNet revenues*

$  166.7$
-$  166.7$  151.8$
-$
51.8Operating expenses:Cost of goods sold

42.3(4.6)

 (a) 

37.734.4(0.0)

 (a) 

34.4Research and development

25.5(1.4)

 (b) 

24.122.2(1.2)

 (b) 

20.9Selling, general and administrative

119.2(27.3)

 (c) 

91.989.5(6.3)

 (c) 

83.2Amortization of purchased intangibles

10.9(10.9)

 (d) 

----Contingent consideration

2.3(2.3)

 (e) 

----Total operating expenses

200.1(46.4)153.8146.1(7.6)138.5Income (loss) from operations

(33.5)46.412.95.77.613.2Interest income (expense), net

(10.0)5.8

 (f) 

(4.2)0.3-0.3Income (loss) before Income taxes

(43.4)52.28.76.07.613.5Income tax benefit

92.4(92.4)

 (g) 

---Net income (loss)

$
48.9$  (40.2)$
8.7$
.0$
7.6$
3.5Net income (loss) per common share:Basic$
.99$
.18$   0.12$
.28Diluted

$
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015   Emerson Ecologics, LLC ... supplements, prescription products and natural health and ... with Anabolic Laboratories, a leading manufacturer of ... new partnership will allow Anabolic Laboratories to ... practitioner segments and provide customers with added ...
(Date:3/2/2015)... BUENA, N.J., March 2, 2015  IGI Laboratories, Inc. (NYSE ... announced its financial results for the fourth quarter and year ... to Date 2014 Highlights , Total revenues of ... of 104% over the same quarter in 2013 , ... 31, 2014, an increase of 85% over the same period ...
(Date:3/2/2015)... March 2, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... and full year ended December 31, 2014. Financial highlights for ... net loss of $5.3 million, or $0.04 per share. This ... of $22.0 million, or $0.19 per share, for the fourth ... include revenues of $75.3 million and a net loss of ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
... Mass., Aug. 26 Sermo ... physicians, today announced a free Sermo Report titled, " ... covers physician opinions about the introduction of an investigational ... to the results, 46% of physicians feel that ticagrelor ...
... Cardioxyl Pharmaceuticals, Inc. , a clinical-stage pharmaceutical ... disease, today announced that it has initiated a dose-defining ... for the treatment of patients with acute decompensated heart ... at the time of discharge from U.S. hospitals and ...
Cached Medicine Technology:Sermo Report Indicates that Ticagrelor is Likely to Affect the Standard of Care for ACS Patients 2Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 2Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 3Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 4
(Date:3/2/2015)... 2015 Gummy smile reduction expert, ... reshaping can involve one or several procedures to reduce the ... tissue for a more even gum line. Dr. Farnoosh is ... that can permanently lighten discolored or naturally dark gums. ... involves a personalized treatment plan to address a patient’s specific ...
(Date:3/2/2015)... Burns Engineering's Lab-to-Lab Calibration Service offers ... Platinum Resistance Thermometers (SSPRTs) and industrial Resistance Temperature ... . . . guaranteed. Their metrology ... 200706-0), ISO 9001 and 17025 Certified and provides ... to 500°C, both ITS-90 and Callendar-van Dusen calibrations ...
(Date:3/2/2015)... Over the last five years the ultrasound ... to expand their geographic presence and achieve economies of ... $6.2 billion by 2019 at CAGR of 5.1% from ... and Canada and a major part of Europe are ... as Asia-Pacific including China and India, Latin America and ...
(Date:3/2/2015)... This year, the National Multiple Sclerosis Society’s annual awareness ... people across the country to unite, raise awareness, ... their best lives. MS Awareness Week is a special week ... the Society’s vision of a world free of MS. ... the central nervous system, interrupts the flow of information within ...
(Date:3/2/2015)... 02, 2015 Atlantic Information Services, Inc. ... AIS’s Directory of Health Plans: 2015 , the all-new ... the U.S. health plan market, with enrollment data and ... States. , Available as a printed book containing ... trends in quick-view tables and charts, as well as ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2
... 21 Secretary of Veterans,Affairs Dr. James B. Peake ... panels that will make recommendations on ways the Department,of ... prevention,suicide research and suicide education., "There is nothing ... one of,the great men or women who have served ...
... 1 Day ASV Single Vision Lens Now Available Through Licensed Eye Care ... ... Inc. (OTC,Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops,licenses, manufactures, distributes ... C-VUE(R) 1 Day ASV, which is the,first aspheric, daily disposable contact lens ...
... Leading Pennsylvania Health Insurer Reduce ... DST Health Solutions,today announced an extension of ... health insurer serving nearly 3.4 million,members, for business ... center in Harrisburg, Pa. will,continue to provide business ...
... the Most Promising ... Driving the Future of Technology, SUNNYVALE, Calif., May ... technology in enterprise mobility,today announced that it has won ... most innovative private technology companies based in North,America., ...
... young flight attendant,complains of swelling and tightness in ... her from exercising. Will the ultrasound results indicate,deep ... symptomatology and the frequent presence of comorbidities,make it ... primary care,practice. The Journal of Family Practice has ...
... Thoracic Societys 2008 International Conference in Toronto on Wednesday, May ... young adults. One links low levels of a protein called ... in young women. A second finds that high levels of ... , The data from both studies comes from the ...
Cached Medicine News:Health News:VA Secretary Appoints Panel of National Suicide Experts 2Health News:Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens 2Health News:DST Health Solutions and Independence Blue Cross Extend Business Process Outsourcing Agreement 2Health News:DST Health Solutions and Independence Blue Cross Extend Business Process Outsourcing Agreement 3Health News:Agito Networks Wins Red Herring North America 100 Award Out of More Than 800 Companies 2Health News:Agito Networks Wins Red Herring North America 100 Award Out of More Than 800 Companies 3Health News:CME Publication Gives Clinicians a Leg Up in Treating Disorders of the Lower Extremities 2Health News:Studies provide insights into lung disease and lung function in young adults 2Health News:Studies provide insights into lung disease and lung function in young adults 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: